← Open Payments lookup

RAYMOND BROWN: Open Payments

NPI 1730313305 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$646 in 18 payments from 8 companies in 2025. Trend: 2023 $541 · 2024 $679 · 2025 $646

Food & beverage: $646
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.2$177
E.R. Squibb & Sons, L.L.C.8$152
Janssen Scientific Affairs, LLC1$149
Otsuka America Pharmaceutical, Inc.2$56
ABBVIE INC.2$48
Lundbeck LLC1$25
Alkermes, Inc.1$24
Otsuka Pharmaceutical Development & Commercialization, Inc.1$16

Products named: INGREZZA, COBENFY, INVEGA SUSTENNA, REXULTI, VRAYLAR, ABILIFY ASIMTUFII, ARISTADA, ABILIFY MAINTENA.

Industry payments across DC — which companies pay providers there.